Gastric cancer is a deadly disease and remains the third leading cause of cancer-related
death worldwide. The 5-year overall survival rate of patients with early-stage localized …

The coding regions account for only a small part of the human genome, and the remaining
vast majority of the regions generate large amounts of non-coding RNAs. Although non …

Gastric carcinoma (GC) ranks fifth in terms of cancer morbidity and third in cancer-related
death worldwide and imposes enormous health and economic burdens. The molecular …

Gastric cancer (GC) is a malignant tumour with high lethality. Accruing evidence elucidates
the critical adjusting role of long non-coding RNA (lncRNAs) in human cancers. DDX11 …

Gastric adenocarcinoma, which originates from the gastric mucosal epithelium, has the
highest incidence among various malignant tumours in China. As a crucial long non-coding …

Cantharidin (CTD) is a traditional Chinese medicine that shows an anticancer effects in
multiple types of cancer cells. However, the mechanism of CTD anti-cancer function in …

Gastric cancer (GC) remains an important malignancy worldwide with poor prognosis. Long
noncoding RNAs (lncRNAs) can markedly affect cancer progression. Moreover, lncRNAs …

Abstract The Epstein–Barr virus (EBV) is associated with a variety of cancers, including
gastric cancer, which has one of the highest mortality rates of all human cancers. Long non …

Long non-coding RNAs (lncRNAs) have been shown to play important roles in many human
diseases. However, their functions and mechanisms in tumorigenesis and development …

Gastric cancer (GC) is a high mortality disease. We studied the function and mechanism of
long non-coding RNA prostate cancer-associated transcript 6 (lncRNA PCAT6) on cell …